Cargando…
IP receptor-dependent activation of PPARγ by stable prostacyclin analogues
Stable prostacyclin analogues can signal through cell surface IP receptors or by ligand binding to nuclear peroxisome proliferator-activated receptors (PPARs). So far these agents have been reported to activate PPARα and PPARδ but not PPARγ. Given PPARγ agonists and prostacyclin analogues both inhib...
Autores principales: | Falcetti, Emilia, Flavell, David M., Staels, Bart, Tinker, Andrew, Haworth, Sheila. G., Clapp, Lucie H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1997304/ https://www.ncbi.nlm.nih.gov/pubmed/17624303 http://dx.doi.org/10.1016/j.bbrc.2007.06.135 |
Ejemplares similares
-
The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels
por: Cunningham, Kevin P., et al.
Publicado: (2021) -
Muscle Injuries Induce a Prostacyclin‐PPARγ/PGC1a‐FAO Spike That Boosts Regeneration
por: Luo, Lanfang, et al.
Publicado: (2023) -
Prostacyclin Analogue Beraprost Inhibits Cardiac Fibroblast Proliferation Depending on Prostacyclin Receptor Activation through a TGF β-Smad Signal Pathway
por: Chen, Yun, et al.
Publicado: (2014) -
Coordinated Regulation of PPARγ Expression and Activity through Control of Chromatin Structure in Adipogenesis and Obesity
por: Eeckhoute, Jérôme, et al.
Publicado: (2012) -
Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag
por: Kaufmann, Priska, et al.
Publicado: (2015)